| 发明名称 |
USE OF PROSTAGLANDIN E1 (PGE1) AND MISOPROSTOL FOR TREATING CHRONIC MYELOGENOUS/MYELOID LEUKEMIA (CML) |
| 摘要 |
Disclosed are methods and compositions for treating a patient having chronic myelogenous/myeloid leukemia (CML). The methods utilize and the compositions include prostaglandin E1 (PGE1) or Misoprotol. |
| 申请公布号 |
US2015342961(A1) |
申请公布日期 |
2015.12.03 |
| 申请号 |
US201514729937 |
申请日期 |
2015.06.03 |
| 申请人 |
Xue Hai-Hui |
发明人 |
Xue Hai-Hui |
| 分类号 |
A61K31/5575;A61K31/506 |
主分类号 |
A61K31/5575 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating chronic myelogenous/myeloid leukemia (CML) comprising:
administering prostaglandin E1 or a synthetic analog of prostaglandin E1 to a patient having chronic myelogenous/myeloid leukemia (CML). |
| 地址 |
Iowa City IA US |
